Literature DB >> 6301669

Prevalence of antibodies to hepatitis A virus in Nova Scotia children.

M D Crewe, J A Embil, J B Garner.   

Abstract

Blood samples from 304 children aged 6 months to 16 years were tested by radioimmunoassay for antibodies to hepatitis A virus (anti-HAV). Of several factors examined for a possible association with the prevalence of anti-HAV--age, sex, race, geographic location and presence of malignant disease--only age showed a positive correlation with the prevalence of these antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301669      PMCID: PMC1875328     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Age-specific prevalence of hepatitis A virus antibody in Thailand.

Authors:  D S Burke; R Snitbhan; D E Johnson; R M Scott
Journal:  Am J Epidemiol       Date:  1981-03       Impact factor: 4.897

2.  Evaluation of a finger-stick specimen collection method for seroepidemiology of antibody to hepatitis A virus.

Authors:  K A McCaustland; W W Bond; D W Bradley; M S Favero; N J Petersen; J E Maynard
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

3.  Antibody to hepatitis A virus in Liberians.

Authors:  M Willcox; J Brohult; I Olsson; E Bengtsson
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

4.  Antibody to hepatitis A virus in young inmates.

Authors:  E S McFarlane; J A Embil
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

5.  Prevalence of antibody to hepatitis A virus in a Canadian Inuit community.

Authors:  G Y Minuk; J G Waggoner; R Jernigan; L E Nicolle; B Postl; J H Hoofnagle
Journal:  Can Med Assoc J       Date:  1982-11-01       Impact factor: 8.262

6.  Capsaicin treatment in adult Wistar-Kyoto and spontaneously hypertensive rats: effects on nociceptive behavior and cardiovascular regulation.

Authors:  R M Virus; M M Knuepfer; D Q McManus; M J Brody; G F Gebhart
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

7.  Viral hepatitis A and B: a seroepidemiological study of a non-hepatitic Sydney population.

Authors:  C R Boughton; R A Hawkes; V Ferguson
Journal:  Med J Aust       Date:  1980-02-23       Impact factor: 7.738

8.  Prevalence of antibodies to Hepatitis A antigen in sera from patients with haematological malignancies.

Authors:  E S McFarlane; J A Embil
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Epidemiology of hepatitis A in Amsterdam, October 1978--December 1979.

Authors:  R A Coutinho; W Duermeyer; J van der Veen
Journal:  J Virol Methods       Date:  1980-12       Impact factor: 2.014

10.  Prevalence of antibodies to hepatitis A antigen in patients attending a clinic for treatment of sexually transmitted diseases.

Authors:  E S McFarlane; J A Embil; F R Manuel; M Gorelick
Journal:  Sex Transm Dis       Date:  1980 Apr-Jun       Impact factor: 2.830

  10 in total
  3 in total

1.  Prevalence of hepatitis A virus antibody among Navajo school children.

Authors:  R Williams
Journal:  Am J Public Health       Date:  1986-03       Impact factor: 9.308

2.  Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.

Authors:  Arni S R Srinivasa Rao; Maggie H Chen; Ba' Z Pham; Andrea C Tricco; Vladimir Gilca; Bernard Duval; Murray D Krahn; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2006-12-05       Impact factor: 3.090

Review 3.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.